## Abstract The aim of this study was to elucidate the reduction of hepatocarcinogenesis by prolonged interferon (IFN) monotherapy in aged chronic hepatitis C patients. Inclusion criteria were biopsyβproven chronic hepatitis or liver cirrhosis, 60 years and over, elevated serum aminotransferase and
β¦ LIBER β¦
Efficacy of interferon therapy for aged patients with chronic hepatitis C
β Scribed by Yasuji Arase; Hiromitsu Kumada
- Publisher
- Springer Japan
- Year
- 2004
- Tongue
- English
- Weight
- 78 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prolonged-interferon therapy reduces hep
β
Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi
π
Article
π
2007
π
John Wiley and Sons
π
English
β 129 KB
Interferon therapy for aged patients wit
β
Yasuharu Imai; Akinori Kasahara; Hideo Tanaka; Takeshi Okanoue; Naoki Hiramatsu;
π
Article
π
2004
π
Springer Japan
π
English
β 208 KB
Efficacy of interferon retreatment after
β
Yasuji Arase; Kenji Ikeda; Akihito Tsubota; Yoshiyuki Suzuki; Satoshi Saitoh; Ma
π
Article
π
2004
π
Springer Japan
π
English
β 142 KB
Long-term therapeutic efficacy of interf
β
Takeda, Tadashi ;Kuroki, Tetsuo ;Fukuda, Katsuhiko ;Yabusako, Tsuneo ;Nishiguchi
π
Article
π
1993
π
Springer-Verlag
π
English
β 334 KB
Efficacy of interferon alfa therapy in c
β
Gotaro Yamada; Masahiro Takatani; Fumitoshi Kishi; Michiko Takahashi; Toshihiko
π
Article
π
1995
π
John Wiley and Sons
π
English
β 557 KB
TAKA0 TSUJI,~ SADAHITO SHIN,2 MASASHI TA"03, MICKEY s. URDEA,4 AND JANICE A. KOLBERG4 To clarify the viral factors that may predict the therapeutic effect of interferon (IFN) in chronic hepatitis C (CHC) patients, we investigated the quantitative serum hepatitis C virus (HCV) RNA level, genotype, a
Efficacy of re-treatment with pegylated
β
Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O
π
Article
π
2011
π
Springer Japan
π
English
β 297 KB